Drugs & TargetsFree AACR Project GENIE begins five-year research project with $36M in industry funding November 01, 2019Vol.45 No.41
Drugs & TargetsFree European Commission approves Astellas’ Xospata indication for relapsed or refractory AML November 01, 2019Vol.45 No.41
Drugs & TargetsFree FDA grants Cytotron Breakthrough Device Designation for breast, liver and pancreatic cancers November 01, 2019Vol.45 No.41
Drugs & TargetsFree MD Anderson, Ziopharm Oncology to expand TCR-T Program November 01, 2019Vol.45 No.41
Drugs & Targets FDA approves indication for Zejula in advanced ovarian, fallopian tube, or primary peritoneal cancer October 25, 2019Vol.45 No.40
Drugs & Targets FDA approves test to identify patients eligible for treatment with Zejula in late-line Ovarian Cancer October 25, 2019Vol.45 No.40
Drugs & Targets European Commission approves dosing schedules for Opdivo in melanoma October 25, 2019Vol.45 No.40
Drugs & Targets FDA approves Fast Track designation for bemcentinib in AML indication October 25, 2019Vol.45 No.40
Drugs & Targets Abernethy, Shuren, issue statement on FDA breast implant labelling guidance October 25, 2019Vol.45 No.40
Drugs & Targets FDA grants first-ever modified risk orders to eight smokeless tobacco products October 25, 2019Vol.45 No.40
